CVS Health (NYSE:CVS) PT Raised to $75.00 at Evercore ISI

CVS Health (NYSE:CVS – Get a Free Report) The target price was upped by analysts at Evercore ISI from $62.00 to $75.00 in a research report issued on Tuesday, Benzinga reports. The brokerage currently has an “outperform” rating on the pharmacy operator’s stock. Evercore ISI’s price target indicates a potential upside of 13.71% from the stock’s previous close.

A number of other research firms have also recently commented on CVS. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Barclays cut their price target on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday, August 8th. Finally, Wells Fargo & Company boosted their price objective on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research note on Monday. August 12. Ten analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The company has an average rating of “Moderate Buy” and a consensus price target of $74.05, based on data from MarketBeat.

Get the latest stock analysis on CVS Health

CVS Health Price Performance

Shares of CVS Health stock opened at $65.96 on Tuesday. The stock’s 50-day moving average is $58.72, and its two-hundred-day moving average is $61.16. The stock has a market cap of $82.80 billion, a price-to-earnings ratio of 11.59, a PEG ratio of 0.81 and a beta of 0.54. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66, and a current ratio of 0.86. CVS Health has a 52-week low of $52.77 and a 52-week high of $83.25.

CVS Health (NYSE:CVS – Get Free Report ) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.10. The business had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. CVS Health’s revenue was up 2.6% compared to the same quarter last year. In the same quarter last year, the company posted earnings of $2.21 per share. On average, equities analysts anticipate that CVS Health will post 6.51 earnings per share for the current year.

Institutional investors are weighing in on the health of CVS

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CVS. Deerfield Management Company LP Series C acquired a new position in CVS Health in the second quarter valued at $57,584,000. Susquehanna Fundamental Investments LLC grew its position in shares of CVS Health by 27.9% in the second quarter. Susquehanna Fundamental Investments LLC now owns 665,451 shares of the pharmacy operator’s stock worth $39,302,000 after purchasing an additional 145,158 shares in the last quarter. Steph & Co. raised its position in CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares during the period. Douglas Lane & Associates LLC increased its position in CVS Health by 1.6% in the first quarter. Douglas Lane & Associates LLC now owns 1,084,256 shares of the pharmacy operator’s stock valued at $86,480,000 after acquiring an additional 16,840 shares during the period. Finally, First Hawaiian Bank raised its stake in shares of CVS Health by 30.1% in the second quarter. First Hawaiian Bank now owns 100,302 shares of the pharmacy operator’s stock worth $5,924,000 after acquiring an additional 23,213 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s shares.

CVS Health Company Profile

(Get a free report)

CVS Health Corporation provides healthcare solutions in the United States. It operates through the Health Care Benefits, Health Services, and Pharmacy & Consumer Health segments. The Healthcare Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services.

Read more

Get news and reviews for CVS Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CVS Health and related companies with MarketBeat.com’s FREE daily email newsletter.